BGBarbara Górnicka

Barbara Górnicka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Barbara Górnicka has a total of 150 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Adrenal cyst with both Müllerian and mesothelial differentiation - a clinicopathological and immunohistochemical study with implications for histogenesis

    by Łukasz Koperski, Benedykt Szczepankiewicz, Paweł Pihowicz, Łukasz Fus, Ewa Wolińska, Barbara Górnicka

    True epithelial-lined cysts are rare forms of adrenal cystic lesions, the pathogenesis of which is still not fully understood. In this report we present a case of an adrenal cyst diagnosed incidentally on imaging in a 31-year-old, previously healthy, obese woman. Due to non-specific hormonal disorders and enlargement of the lesion, a right-sided laparoscopic adrenalectomy was performed. The cyst was lined predominantly by ciliated cuboidal-to-columnar, Müllerian-type epithelium, and focally by flat-to-cuboidal, mesothelium-like lining. Immunohistochemistry demonstrated a strong positive reaction in the cells of both types of lining for CKAE1+E3, CK19, CK7 and WT1, and both had a negative reaction for CK20, CD34, Melan-A, SF1, TTF1, SMA and CDX2. The cells of the ciliated cuboidal-to-columnar epithelium were strongly positive for PAX8, ER, Ep-CAM and EMA, focally positive for PR, and were negative for calretinin, whereas the cells of the flat-to-cuboidal lining were positive for calretinin and podoplanin and showed only a weak positive response in individual cells for PAX8, EMA and Ep-CAM, but were negative for ER and PR. This is the first reported case of an adrenal ciliated epithelial cyst with Müllerian differentiation (confirmed immunohistochemically) in the English literature. The differences in morphology and immunophenotype of the two types of lining (epithelial Müllerian phenotype versus mesothelial phenotype), suggest that some adrenal epithelial cysts probably form due to metaplasia of mesothelium-derived lining. A similar mechanism may also be involved in the pathogenesis of at least some of the so-called Müllerian cysts (or inclusions) in other locations.


    • 1 March 2015
      • Vol. 12  (1) , 50-63

    Antigenic profile of muscularis mucosae and muscularis propria of the urinary bladder.

    by Sławomir Poletajew, Ewa Wilczek, Aleksander Wasiutyński, Barbara Górnicka

    Differentiation between the muscularis mucosae (MM) and muscularis propria (MP) of the bladder remains challenging. To identify MM- and MP-specific antigens that could be of potential value for staging of urothelial carcinoma in a pilot study. The expression of 12 protein antigens in 11 human bladder specimens was examined. There were 5 post radical cystectomy specimens and 6 normal bladder autopsy specimens. Antibodies against actin, caldesmon, type IV collagen, cytokeratin, desmin, elastin, fibronectin, filamin, laminin, miotilin, smoothelin, and vimentin were used. Slides were stained with immunohistochemical reagents and assessed using light microscopy. The intensity of the immune reaction within MM and MP was evaluated in a four-level scale as negative and weakly, moderately or strongly positive. The presence of MM was noticed in 63.6% of specimens. The expression of desmin, filamin, and smoothelin was stronger within MP compared to MM in all cases. Stronger reaction with anti-type IV collagen antibodies was noticed within MP in 80% of the cases. In the whole study group, the expression of vimentin was stronger within MM than MP. MM and MP cells are of different antigenic characteristics. This can be used in the microscopic diagnostics of selected cases. The results need to be validated in a series of specimens from transurethral resection.


  • Evolution Of The Results Of 1500 Liver Transplantations Performed In The Department Of General, Transplant And Liver Surgery Medical University Of Warsaw

    by Marek Krawczyk, Michał Grąt, Karolina Grąt, Karolina Wronka, Maciej Krasnodębski, Jan Stypułkowski, Łukasz Masior, Wacław Hołówko, Joanna Ligocka, Paweł Nyckowski, et al.

    Long-term outcomes after liver transplantations performed in the Department of General, Transplant and Liver Surgery are comparable to those achieved in the largest transplant centers worldwide and are continuously improving despite increasing recipient age and wider utilization of organs procured from older donors.


  • Functional analysis of newly discovered microRNA deregulated in papillary thyroid carcinoma

    by Monika Maciag, Anna Kubiak, Michal Swierniak, Kinga Dymecka, Monika Kolanowska, Lukasz Koperski, Barbara Gornicka, Elzbieta Stachlewska, Krystian Jazdzewski

    Introduction: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy where alterations in the RET/PTC–RAS–BRAF signaling pathway and deregulation of microRNA (miRNA) expression are suggested to be major mechanism of pathogenesis. MicroRNAs are small non-coding RNA molecules that recognize specific sequences in 3′UTR of target gene and prevent from its translation. Our recent deep sequencing studies of thyroid tissue transcriptome revealed a putative novel small non-coding RNA, encoded within PAX8 gene. In silico analysis confirmed that the short non-coding sequence could be miRNA. We aimed to investigate the role of newly identified microRNA (miR-PAX8) in thyroid carcinogenesis. Methods and results: To confirm functionality of newly discovered RNA, pcDNA3 vector expressing pri-miRNA was transfected into U2-OS cells. TaqMan assay confirmed the proper processing towards mature miRNA in transfected cells. Analysis of PAX8 mRNA and miR-PAX8 expression in 42 pairs of PTC and matched control tissue showed 28% (P=0.02) decrease of miR-PAX8 and 40% (P=0.001) decrease of PAX8 mRNA in tumor compared with noncancerous tissue (correlation r=0.57, P=0.00008). Using in silico analysis we chose CTBP1 gene as a target gene of miR-PAX8 for further studies. qPCR analysis revealed 1.6-fold (P=0.001) increase of CTBP1 mRNA in PTC compared to control tissue that could potentially results from miR-PAX8 decrease (correlation r=−0.45, P=0.002). Direct interaction of miR-PAX8 with CTBP1 transcript was confirmed by luciferase assay using vector with CTBP1 3′UTR cloned downstream to luciferase. Cells transfected with pGL3-3′UTR construct and vector expressing pre-miRNA revealed 17% (P=0.002) decrease in luciferase expression. Conclusions: We demonstrated that the newly discovered non-coding RNA is functional microRNA that is downregulated in PTC tissue. As CTBP1 mediates repression of several tumor suppressors, interaction of miR-PAX8 with CTBP1 transcript suggests that novel miRNA could be involved in PTC development. To strengthen this hypothesis further studies including Western blot and flow cytometry analysis will be performed.

    • 1 January 2013
      • Vol. 67  (1) , 5-10, 93

    Results of liver transplantation in the Department of General, Transplant and Liver Surgery at the Medical University of Warsaw in patients with chronic hepatitis B and C viruses infection.

    by Marek Krawczyk, Michał Grat, Oskar Kornasiewicz, Zbigniew Lewandowski, Krzysztof Barski, Joanna Ligocka, Karolina Grat, Arkadiusz Antczak, Michał Skalski, Waldemar Patkowski, et al.

    Cirrhosis related to hepatitis C virus (HCV) and hepatitis B virus (HBV) infection is the most frequent indication for liver transplantation worldwide. Progress in prophylaxis of posttransplant HBV recurrence has led to major improvements in long-term outcomes of patients after liver transplantation. Conversely, impaired posttransplant survival of patients with HCV infection was reported in several studies, mainly due to recurrence of viral infection. The purpose of this study was to compare long-term results of liver transplantation between patients with HBV monoinfection, HCV monoinfection and HBV/HCV coinfection. A total of 1090 liver transplantations were performed in the Department of General, Transplant and Liver Surgery in cooperation with the Department of Immunology, Internal Medicine, and Transplantology at the Transplantation Institute Medical University of Warsaw between December 1994 and May 2012. After exclusion of patients with cirrhosis of non-viral etiology, patients with malignant tumors, and patients with acute liver failure, the final study cohort comprised 209 patients with HBV (HBV+/HCV- subgroup; n = 56) or HCV (HBV-/HCV+ subgroup; n = 119) monoinfection or HBV/HCV coinfection (HBV+/HCV+; n = 34). These subgroups of patients were compared in terms of long-term results of transplantations, defined by 5-year patient and 5-year graft survival estimates. Overall and graft survival rates after 5-years for the whole study cohort were 74.5% and 72.6%, respectively. Five-year overall survival was 70.4% for patients within the HBV+/HCV- subgroup, 77.8% for patients within the HBV-/HCV+ subgroup, and 68.5% for patients within the HBV+/HCV+ subgroup. The corresponding rates of graft survival were 67.0%, 76.3%, and 68.5% for patients within the HBV+/HCV-, HBV-/ HCV+, and HBV+/HCV+ subgroups, respectively. Observed differences were non-significant, both in terms of overall (p = 0.472) and graft (p = 0.461) survival rates. Both overall and graft survival rates after liver transplantations performed in the Department of General, Transplant and Liver Surgery in cooperation with the Department of Immunology, Internal Medicine, and Transplantology at the Transplantation Institute Medical University of Warsaw in patients with HBV and HCV infection are comparable to those reported by other European and American centers. In contrast to other studies, obtained results do not confirm the negative impact of HCV infection on long-term outcomes of patients.


    • 1 January 2012
      • Vol. 63  (4) , 308-11

    Adrenocortical oncocytoma - a case report.

    by Joanna Rutkowska, Elżbieta Bandurska-Stankiewicz, Ewa Kuglarz, Ewa Aksamit-Białoszewska, Dorota Wiatr-Bykowska, Maciej Otto, Lukasz Koperski, Barbara Górnicka

    Adrenocortical oncocytoma is found very rarely. Most such tumours are benign and nonfunctioning. We report the case of a nonfunctioning adrenocortical oncocytoma located in the right adrenal gland in a 35-year-old man. The patient was tested because of arrhythmia. An adrenal mass of 68 × 64 mm was found during ultrasonography, followed by CT examination. Physical examination indicated obesity with BMI of 32.8 kg/m(2). Abnormal laboratory findings based on an oral glucose tolerance test revealed impaired glucose tolerance and elevated cholesterol level. The patient underwent a laparotomy for a pathological mass located in the right adrenal gland. The pathology report confirmed adrenocortical oncocytoma of uncertain malignant potential. The patient is still alive with no metastases, 37 months after the surgery. Adrenocortical oncocytoma, although extremely rare, should be considered in the differential diagnosis of adrenal tumours.


    • 1 January 2011
      • Vol. 69  (5) , 482

    [Cardiac tamponade as the initial symptom of lung cancer].

    by Bartosz Puchalski, Marta Starczewska, Łukasz Koperski, Jarosław Żyłkowski, Franciszek Majstrak, Barbara Górnicka, Krzysztof Filipiak

    We report a case of a 55 year-old woman in whom cardiac tamponade was first symptom of lung cancer. The pericardium is involved in about 12% of patients with malignant disease. Cardiac tamponade is life-threatening situation. In our case diagnosis was made on clinical symptoms and echocardiography. Only urgent pericardiocentesis performed under echocardiograhic guidance can save patient's life. In described case final diagnosis was made on histological examination. We should take into the consideration lung cancer in differentiation causes of cardiac tamponade.

    • 17 December 2009
      • Vol. 14  (4) , 61-70

    Role of C3d and C4d complement fragments in the diagnostics of acute allograft rejection after transplantations.

    by Beata Gierej, Barbara Górnicka, Aleksander Wasiutyński

    Transplantation is a widely recognized method of treatment at the terminal stages of many renal, cardiac, hepatic and pulmonary diseases. Despite considerable advances in that field, graft rejection is still an important clinical problem. The reaction of the graft recipient to an organ presenting foreign antigens is dependent on complex immune mechanisms, involving both acquired and congenital immune responses. In most general terms, cellular and humoral immunity can be distinguished. The kidneys and the heart are the organs whose acute humoral rejection has been thoroughly investigated and defined, and the role of C4d and C3d fragments of the complement system has been confirmed by numerous studies. The studies concerning C4d and C3d expression in patients with acute humoral lung and liver rejection conducted to date have given contradictory results. Some of them confirm, while others fail to confirm, the correlation between their increased expression and AHR. From the practical point of view, C4d and C3d could be used in liver transplantology for differential diagnostics of acute graft rejection and recurrence of HCV infection. A few preliminary studies suggest the usefulness of these markers in the diagnostics of AMR and differentiation between both liver pathologies. There are only single reports concerning the role of C4d complement fragment in the diagnostics of acute rejection with a humoral component in case of small intestine grafts, as well as complex ones such as the hands and face, and their results suggests that these complement fragments are not important markers of acute rejection of these organs.


    • 1 January 2007
      • Vol. 12  (1) , 19-26

    Small bowel transplantation--harvesting technique and graft preparation in pigs.

    by Mariusz Fraczek, Piotr Hevelke, Marcin Kotulski, Maciej Słodkowski, Agata Kacka, Monika Wojtasik, Barbara Górnicka, Michał Korba, Tomasz Guzel, Bogna Ziarkiewicz-Wróblewska, et al.

    In more and more frequently occurring short bowel syndrome, requiring total parenteral nutrition therapy, the complications of the latter not seldom prevent its use. The idea of treating these patients with small bowel transplantation pushed the authors to start the program aiming at development of small bowel harvesting, preservation and transplantation technique in experimental settings. Additionally, an attempt to find which, if any, and to what extent, histological changes of the preserved bowel may be of prognostic value for the early transplant failure. The experiment was carried out on 20 pigs. Two distinct techniques, corresponding to two clinical circumstances in humans, were tested. In the first group of animals, the small bowel was harvested during a model of multivisceral operation, corresponding to the organ harvesting from a brain-dead donor. In the remaining pigs, an isolated segment of the small bowel was explanted, constituting a model of a living related donor surgery. All small bowels were preserved in hypothermia, in Celsior preserving solution for a different, predefined period. During 16 procedures, the harvested small bowel segment was replanted in the same donor, using different vascular anastomotic techniques. Vascular thrombosis was significantly more frequent in grafts anastomosed by end-to-side technique, as well as in more proximal bowel segments, regardless the anastomotic technique. Following two hours of reimplantation, excised bowel segments did not demonstrate significant differences on histological examination, as compared to the hypothermia-preserved segments (from the same donor) of the same age from primary excision. In most cases, the increase of mucosal damage with preservation time was observed, although statistical significance was reached only for the presence of erosions and necrotic lesions. On the basis of this experiment one may state, that an ileal graft, assuring the long vascular pedicle (derived from ileocolic vessels) and vascular end-to-end anastomoses are at lesser risk of early vascular thrombosis. While applying the presented technique of purging the graft and its preservation, the act of transplantation itself practically does not influence the histological structure of the bowel, thus is not related to the early graft failure which seems to depend, to the greatest extent, upon the technical aspects of the procedure.


    • 1 January 2007
      • Vol. 12  (3) , 28-32

    Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.

    by Urszula Ołdakowska-Jedynak, Leszek Paczek, Bartosz Foroncewicz, Krzysztof Mucha, Paweł Nyckowski, Krzysztof Zieniewicz, Bogna Ziarkiewicz-Wróblewska, Jacek Ziółkowski, Tomasz Pilecki, Waldemar Patkowski, et al.

    Patients undergoing liver transplantation (ltx) for hepatitis B-related liver disease are prone to recurrence. Historically, ltx has been associated with aggressive reinfection and poor survival results. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin(HBIG). Antiviral prophylaxis with lamivudine appears to reduce hepatitis B virus (HBV)infection after liver transplantation. However, HBV recurrence remains common. This study retrospectively evaluated a single center's experience with cohort of patients who underwent ltx for HBV-related chronic and acute liver disease. We examined the effect of a combined of intravenous HBIG and lamivudine viral prophylactic therapy on HBV recurrence and the outcome of ltx. Eighteen patients underwent transplantation for HBV liver disease at our center. Before ltx all patients were HBsAg positive and 3 were HBV DNA positive. HBV recurrence was defined by HBsAg seropositivity after ltx. HBIG monotherapy was used in 2 (15%) patients, lamivudine monotherapy in 4 (31%), and lamivudine and HBIG combination in 7 (54%). Hepatocellular carcinoma was present in 1 patients. Maintenance immunosuppression regimens consisted of either a cyclosporine- or tacrolimus-based drug regimen. Overall 1-year and 3-years patient survival rates were 60% and 60%, respectively, and 1-year and 3-years graft survival was 60% and 60% respectively. Among 7 patients receiving receiving combination HBIG and lamivudine, one patient died. He was retransplanted 9 months after first transplantation secondary to biliary complication caused by late hepatic artery thrombosis. Of the 6 surviving patients, 4 patients currently have normal allograft function. Allograft dysfunction developed in two patients because of ischemic biliary strictures. Among seven patients, who received HBIG and lamivudine, one did not receive proper administration of the prophylactic regimen and graft became infected. Serologic HBV recurrence was diagnosed after 9 months after transplantation. Liver transplantation for HBV under combination viral prophylaxis results in good survival rates. A good outcome is possible after liver transplantation for HBV liver disease using HBIG dosed by pharmacokinetic parameters in combination with lamivudine. Viral prophylactic therapy has effectively reduced HBV recurrence and prolonged survival outcome.